Lataa...
Intra-tumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas
BRAF mutations exist in numerous types of cancer, including melanomas, colorectal cancers and lung cancers. The V600E-specific inhibitor vemurafenib has marked clinical activity in patients with BRAF V600E-mutated melanoma. However, there are many cases of resistance to vemurafenib. This may be due...
Tallennettuna:
| Julkaisussa: | Exp Ther Med |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4471699/ https://ncbi.nlm.nih.gov/pubmed/26136882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2298 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|